Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
EV/Core EBITDA

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 42.30-6.02-4.82-2,930.49

What is the latest EV/Core EBITDA ratio of ONESOURCE SPECIALTY PHARMA ?

The latest EV/Core EBITDA ratio of ONESOURCE SPECIALTY PHARMA is 42.30 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202542.30
Mar2024-6.02
Mar2023-4.82
Mar2022-2,930.49

How is EV/Core EBITDA of ONESOURCE SPECIALTY PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 42.3
Positive
Mar2024 -6.02
Negative
Mar2023 -4.82
Negative
Mar2022 -2930.49 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare EV/Core EBITDA ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹18,065.3 Cr 2.7% -2.5% -14.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,530.0 Cr -0.4% 0.9% 19.6% Stock Analytics
DIVIS LABORATORIES ₹219,675.0 Cr -1.2% 21.1% 29.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,970.0 Cr -2.3% 0.3% 34.8% Stock Analytics
CIPLA ₹117,947.0 Cr 0.7% 1.5% -2% Stock Analytics
DR REDDYS LABORATORIES ₹96,601.2 Cr -0.3% -7.1% -3.9% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

2.7%

-2.5%

-14.6%

SENSEX

-0.1%

2.4%

-3.3%


You may also like the below Video Courses